Literature DB >> 35166963

Association between epicardial adipose tissue and recurrence of atrial fibrillation after ablation: a propensity score-matched analysis.

Min Yang1, Wenrui Bao1, Zhihan Xu2, Le Qin1, Ning Zhang1,3, Fuhua Yan1, Wenjie Yang4.   

Abstract

To assess the association between epicardial adipose tissue (EAT) index derived from cardiac computed tomography and atrial fibrillation (AF) recurrence after ablation by comparing with a propensity score matched non-recurrence AF patients. A total of 506 patients with AF recurrence and 174 patients without AF recurrence were enrolled in this retrospective study. Density and volume of total EAT surrounding the heart (Total-EAT) and EAT surrounding the left atrium (LA-EAT) were measured, propensity score matching(PSM) analyses were used to compare the outcomes of the two groups while controlling for confounders. Total-EAT density (HU) value (-81.27 ± 4.67 vs -84.05 ± 3.84, P < 0.001) and LA-EAT density (HU) value (-76.16 ± 4.11 vs -78.83 ± 3.81, P < 0.001) were significantly higher in the patients with AF recurrence than in those without recurrence. LA-EAT density (HU) value was significantly higher than Total-EAT (- 77.50 ± 4.18 vs -82.66 ± 4.49, P = 0.000). In a multiple logistic regression analysis, a higher LA-EAT density (odds ratio: 1.12; 95% CI: 1.02-1.22, p = 0.015) was significantly associated with the AF recurrence after adjusting for other risk factors. The LA-EAT density plays an important role in the AF recurrence after ablation. Assessment of LA-EAT density can improve ablation outcomes by refining patient selection.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Atrial fibrillation; Epicardial adipose tissue; Propensity score matching; Recurrence

Year:  2022        PMID: 35166963     DOI: 10.1007/s10554-022-02557-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  38 in total

1.  Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation.

Authors:  Hsuan-Ming Tsao; Wei-Chih Hu; Mei-Han Wu; Ching-Tai Tai; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Tsu-Juey Wu; Ming-Huei Sheu; Cheng-Yen Chang; Shih-Ann Chen
Journal:  Am J Cardiol       Date:  2011-03-15       Impact factor: 2.778

2.  Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.

Authors:  Daniele Pastori; Pasquale Pignatelli; Francesco Angelico; Alessio Farcomeni; Maria Del Ben; Tommasa Vicario; Tommaso Bucci; Valeria Raparelli; Roberto Cangemi; Gaetano Tanzilli; Gregory Y H Lip; Francesco Violi
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

3.  Causes of Death in Anticoagulated Patients With Atrial Fibrillation.

Authors:  Antonio Gómez-Outes; Julián Lagunar-Ruíz; Ana-Isabel Terleira-Fernández; Gonzalo Calvo-Rojas; Maria Luisa Suárez-Gea; Emilio Vargas-Castrillón
Journal:  J Am Coll Cardiol       Date:  2016-12-13       Impact factor: 24.094

4.  Pericardial fat is independently associated with human atrial fibrillation.

Authors:  M Obadah Al Chekakie; Christine C Welles; Raymond Metoyer; Ahmed Ibrahim; Adam R Shapira; Joseph Cytron; Peter Santucci; David J Wilber; Joseph G Akar
Journal:  J Am Coll Cardiol       Date:  2010-08-31       Impact factor: 24.094

5.  Catheter ablation is established as a treatment option for atrial fibrillation--is catheter ablation established as a treatment option of atrial fibrillation? (Pro).

Authors:  Atsushi Takahashi
Journal:  Circ J       Date:  2010-08-12       Impact factor: 2.993

6.  Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study.

Authors:  Staffan Björck; Bo Palaszewski; Leif Friberg; Lennart Bergfeldt
Journal:  Stroke       Date:  2013-08-27       Impact factor: 7.914

Review 7.  Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-analysis of Safety and Efficacy.

Authors:  Fang Yi; Wenbo Hou; Chao Zhou; Yuxia Yin; Shoutao Lu; Cuihai Duan; MingKun Cao; Maoquan Li; Egon Steen Toft; Haijun Zhang
Journal:  J Cardiovasc Pharmacol       Date:  2019-04       Impact factor: 3.105

8.  New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio.

Authors:  Halit Acet; Faruk Ertaş; Mehmet Ata Akıl; Mustafa Oylumlu; Nihat Polat; Abdulkadir Yıldız; Mehmet Zihni Bilik; Murat Yüksel; Zeynettin Kaya; Mehmet Sıddık Ulgen
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-26       Impact factor: 2.357

9.  Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Authors:  Sean D Pokorney; Jonathan P Piccini; Susanna R Stevens; Manesh R Patel; Karen S Pieper; Jonathan L Halperin; Günter Breithardt; Daniel E Singer; Graeme J Hankey; Werner Hacke; Richard C Becker; Scott D Berkowitz; Christopher C Nessel; Kenneth W Mahaffey; Keith A A Fox; Robert M Califf
Journal:  J Am Heart Assoc       Date:  2016-03-08       Impact factor: 5.501

10.  Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study.

Authors:  Hye Young Lee; Pil-Sung Yang; Tae-Hoon Kim; Jae-Sun Uhm; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Sci Rep       Date:  2017-10-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.